Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px
Document › Details

PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification".

Organisations Organisation PathoQuest S.A.S.
  Organisation 2 Illumina Inc. (Nasdaq: ILMN)
  Group Illumina (Group)
Products Product NexSeq System
  Product 2 DNA sequencing service
     


PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following a streamlined and rigorous process. PathoQuest’s Propel Certification is valid for the company’s Biologics Genomic Service projects which utilize Illumina’s NGS library preparation and sequencing protocols.

Propel Certification enables our customers to feel confident that they are receiving the highest quality data, insight, and service when PathoQuest utilizes Illumina’s technology for projects.


   
Record changed: 2019-01-14

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for PathoQuest S.A.S.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px




» top